Health · 1 views

Acute respiratory distress syndrome patients improve with experimental monoclonal antibody treatment

Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS.

Source Medical Xpress AI Summary Updated 1h 38m ago

Story intelligence Beta

Freshness Fresh Updated 1h 38m ago

Confidence Limited Single-outlet story

Coverage Single outlet

Views 1 Community interest

Read time 1 min ~54 words

AI Summary

Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS. A frequent cause of death during the COVID-19 pandemic, ARDS occurs when an inflammatory cascade triggered by infection or injury leaks fluid into the lungs, crashing blood oxygen levels. Nearly 40% of people affected die.

Read full article on Medicalxpress

AI summaries can be wrong sometimes—always verify important details using the source article.